Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine
Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.Methods Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portug...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2025-12-01
|
| Series: | Pulmonology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/25310429.2025.2451456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832584109094862848 |
|---|---|
| author | Tiago Alfaro Filipe Froes Cláudia Vicente Rui Costa Cristina Gavina Rui Baptista António Maio Saraiva da Cunha João Sérgio Neves Pedro Leuschner Sofia Duque Paula Pinto |
| author_facet | Tiago Alfaro Filipe Froes Cláudia Vicente Rui Costa Cristina Gavina Rui Baptista António Maio Saraiva da Cunha João Sérgio Neves Pedro Leuschner Sofia Duque Paula Pinto |
| author_sort | Tiago Alfaro |
| collection | DOAJ |
| description | Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.Methods Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine endorses this position paper with recommendations to prevent RSV-associated disease and its complications in adults through vaccination.Conclusion The RSV vaccine is recommended for people aged ≥50 years with risk factors (chronic obstructive pulmonary disease, asthma, heart failure, coronary artery disease, diabetes, chronic kidney disease, chronic liver disease, immunocompromise, frailty, dementia, and residence in a nursing home) and all persons aged ≥60 years. If it cannot be made available to this population, then the vaccine should be prioritised for individuals aged ≥75 years and those aged ≥50 years with risk factors. The vaccine should preferably be given between September and November and can be co-administered with the influenza vaccine. Ongoing studies on RSV vaccines may justify extending these recommendations in the future. |
| format | Article |
| id | doaj-art-f938ab2770024faf815d414bb81ed3e2 |
| institution | Kabale University |
| issn | 2531-0429 2531-0437 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis |
| record_format | Article |
| series | Pulmonology |
| spelling | doaj-art-f938ab2770024faf815d414bb81ed3e22025-01-27T17:24:33ZengTaylor & FrancisPulmonology2531-04292531-04372025-12-0131110.1080/25310429.2025.2451456Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal MedicineTiago Alfaro0Filipe Froes1Cláudia Vicente2Rui Costa3Cristina Gavina4Rui Baptista5António Maio6Saraiva da Cunha7João Sérgio Neves8Pedro Leuschner9Sofia Duque10Paula Pinto11Portuguese Society of Pulmonology (SPP), Lisbon, PortugalPortuguese Society of Pulmonology (SPP), Lisbon, PortugalPortuguese Association of General and Family Medicine (APMGF), Lisbon, PortugalPortuguese Association of General and Family Medicine (APMGF), Lisbon, PortugalPortuguese Society of Cardiology (SPC), Lisbon, PortugalPortuguese Society of Cardiology (SPC), Lisbon, PortugalPortuguese Society of Infectious Diseases and Clinical Microbiology (SPDIMC), Lisbon, PortugalPortuguese Society of Infectious Diseases and Clinical Microbiology (SPDIMC), Lisbon, PortugalPortuguese Society of Endocrinology, Diabetes and Metabolism (SPEDM), Lisbon, PortugalPortuguese Society of Internal Medicine (SPMI), Lisbon, PortugalPortuguese Society of Internal Medicine (SPMI), Lisbon, PortugalPortuguese Society of Pulmonology (SPP), Lisbon, PortugalBackground Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.Methods Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine endorses this position paper with recommendations to prevent RSV-associated disease and its complications in adults through vaccination.Conclusion The RSV vaccine is recommended for people aged ≥50 years with risk factors (chronic obstructive pulmonary disease, asthma, heart failure, coronary artery disease, diabetes, chronic kidney disease, chronic liver disease, immunocompromise, frailty, dementia, and residence in a nursing home) and all persons aged ≥60 years. If it cannot be made available to this population, then the vaccine should be prioritised for individuals aged ≥75 years and those aged ≥50 years with risk factors. The vaccine should preferably be given between September and November and can be co-administered with the influenza vaccine. Ongoing studies on RSV vaccines may justify extending these recommendations in the future.https://www.tandfonline.com/doi/10.1080/25310429.2025.2451456Respiratory syncytial virusvaccinationolder peoplechronic conditionsrecommendations |
| spellingShingle | Tiago Alfaro Filipe Froes Cláudia Vicente Rui Costa Cristina Gavina Rui Baptista António Maio Saraiva da Cunha João Sérgio Neves Pedro Leuschner Sofia Duque Paula Pinto Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine Pulmonology Respiratory syncytial virus vaccination older people chronic conditions recommendations |
| title | Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine |
| title_full | Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine |
| title_fullStr | Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine |
| title_full_unstemmed | Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine |
| title_short | Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine |
| title_sort | respiratory syncytial virus vaccination in older adults and patients with chronic disorders a position paper from the portuguese society of pulmonology the portuguese association of general and family medicine the portuguese society of cardiology the portuguese society of infectious diseases and clinical microbiology the portuguese society of endocrinology diabetes and metabolism and the portuguese society of internal medicine |
| topic | Respiratory syncytial virus vaccination older people chronic conditions recommendations |
| url | https://www.tandfonline.com/doi/10.1080/25310429.2025.2451456 |
| work_keys_str_mv | AT tiagoalfaro respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT filipefroes respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT claudiavicente respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT ruicosta respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT cristinagavina respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT ruibaptista respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT antoniomaio respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT saraivadacunha respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT joaosergioneves respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT pedroleuschner respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT sofiaduque respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan AT paulapinto respiratorysyncytialvirusvaccinationinolderadultsandpatientswithchronicdisordersapositionpaperfromtheportuguesesocietyofpulmonologytheportugueseassociationofgeneralandfamilymedicinetheportuguesesocietyofcardiologytheportuguesesocietyofinfectiousdiseasesan |